Homicide Outside the Family Sphere: Confession in Police Interrogation, Offender Motivation and Characteristics – An Exploratory Study von Bahary, Pascal, Léveillée, Suzanne

Volltext

BMET-02EVALUATION OF DIFFERENT THERAPEUTIC MODALITIES FOR PRIMARY TREATMENT AND SALVAGE THERAPY AND THEIR RELATIVE COST IN PATIENTS WITH BRAIN METASTASES: A SINGLE INSTITUTION REPO... von Bahary, Pascal, Roberge, David, Lambert, Carole, Masucci, Laura, Bahary, Jean-Paul

Volltext

Refining prostate seed brachytherapy: Comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy von Delouya, Guila, Bahary, Pascal, Carrier, Jean-François, Larouche, Renée-Xavière, Hervieux, Yannick, Béliveau-Nadeau, Dominic, Donath, David, Taussky, Daniel

Volltext

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma von Van Cutsem, Eric, Tempero, Margaret A, Sigal, Darren, Oh, Do-Youn, Fazio, Nicola, Macarulla, Teresa, Hitre, Erika, Hammel, Pascal, Hendifar, Andrew E, Bates, Susan E, Li, Chung-Pin, Hingorani, Sunil R, de la Fouchardiere, Christelle, Kasi, Anup, Heinemann, Volker, Maraveyas, Anthony, Bahary, Nathan, Layos, Laura, Sahai, Vaibhav, Zheng, Lei, Lacy, Jill, Park, Joon Oh, Portales, Fabienne, Oberstein, Paul, Wu, Wilson, Chondros, Dimitrios, Bullock, Andrea J

Volltext

Phase 3, multicenter, randomized study of CPI-613 with modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) as first-line therapy for patients with metastatic adenocarcinoma of the p... von Philip, Philip Agop, Bahary, Nathan, Mahipal, Amit, Kasi, Anup, Rocha Lima, Caio Max Sao Pedro, Alistar, Angela Tatiana, Oberstein, Paul Eliezer, Golan, Talia, Sahai, Vaibhav, Metges, Jean Philippe, Lacy, Jill, Fountzilas, Christos, Lopez, Charles D., Ducreux, Michel, Hammel, Pascal, Salem, Mohamed E., Bajor, David Lawrence, Benson, Al Bowen, Buyse, Marc E., Van Cutsem, Eric

Volltext

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma von Van Cutsem, Eric, Tempero, Margaret A, Sigal, Darren, Oh, Do-Youn, Fazio, Nicola, Macarulla, Teresa, Hitre, Erika, Hammel, Pascal, Hendifar, Andrew E, Bates, Susan E, Li, Chung-Pin, Hingorani, Sunil R, de la Fouchardiere, Christelle, Kasi, Anup, Heinemann, Volker, Maraveyas, Anthony, Bahary, Nathan, Layos, Laura, Sahai, Vaibhav, Zheng, Lei, Lacy, Jill, Park, Joon Oh, Portales, Fabienne, Oberstein, Paul, Wu, Wilson, Chondros, Dimitrios, Bullock, Andrea J

Volltext

HALO 109-301: A randomized, double-blind, placebo-controlled, phase 3 study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients (pts) with previousl... von Tempero, Margaret A., Van Cutsem, Eric, Sigal, Darren, Oh, Do-Youn, Fazio, Nicola, Macarulla, Teresa, Hitre, Erika, Hammel, Pascal, Hendifar, Andrew Eugene, Bates, Susan Elaine, Li, Chung-Pin, De La Fouchardiere, Christelle, Heinemann, Volker, Maraveyas, Anthony, Bahary, Nathan, Layos, Laura, Sahai, Vaibhav, Zheng, Lei, Lacy, Jill, Bullock, Andrea J.

Volltext